Vinpocetine Size:Solid 2 mg 3-thiazol-5-yl)phenyl]methyl}pyrrolidine-2-carboxamide

3-thiazol-5-yl)phenyl]methyl}pyrrolidine-2-carboxamide

4-tetrahydronaphthalen-1-yl)carbamoyl)pyrrolidin-1-yl)-1-cyclohexyl-2-oxoethyl)amino)-1-oxopropan-2-yl)(methyl)carbamate InChI Key CDDABGWUXFFTGQ-MLSLTINKSA-N Smiles CN([C@H](C(N[C@H](C(N1C[C@@H](NC(COCCOCCOCCOCCN)=O)C[C@H]1C(N[C@@H]2CCCC3=CC=CC=C23)=O)=O)C4CCCCC4)=O)C)C(OC(C)(C)C)=O References

Bromosporine (18 μM) has moderate cytotoxicity in HeLa cells

Vidya Balasubramanian

Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy

Vinpocetine Size:Solid 2 mg 3-thiazol-5-yl)phenyl]methyl}pyrrolidine-2-carboxamideVinpocetine, also known as AY 27,255, is a synthetic derivative of the vinca alkaloid vincamine (sometimes described as "a synthetic ethyl ester of apovincamine"), an extract from the lesser periwinkle plant. Vinpocetine has been reported to have cerebral blood flow enhancing and neuroprotective effects, and has been used as a drug in Eastern Europe for the treatment of cerebrovascular disorders and age related memory impairment. Vinpocetine acts as a